Country of Operation
Target income level
- Lower-middle income (20-40%)
- Middle-income (40-60%)
- Higher middle-income (60-80%)
- High-income (80-100%)
- Noncommunicable disease(s)
GlicOnline is a diabetes treatment automation service for all diabetes types and therapeutic stages. Android-cloud based, clinically tested to improve glycemic control and QoL, GlicOnline empowers patients to correctly follow treatment, while improving disease manageability with alarms and data.
The company's mission is to improve the quality of life of patients with diabetes.
Our goal is to improve the DM scenario (in Brazil, 14 million patients, +80% with poor glycemic control, leading to high costs and risks), making it easier to prescribe and follow the complex diabetes treatments, while providing education and enabling manageability.
We believe that many do not follow treatment because they do not understand it, lack the discipline or math skills. GlicOnline was built for those who want to follow treatments, but are unable to do it.
Key program components
1 - Software
In 2002, Floro Dória designed a software that allowed for a quick and easy calculation of insulin dosage. Automating insulin dose calculations, the software enabled more people to follow treatments correctly, thus improving results. Automation improved both adherence, quality of life and glycemic control, removing barriers specially for patients with low-literacy levels, who lack basic math skills.
Quasar was incorporated in 2004, and GlicOnline software has been under constant development pursuing three goals: empower patients and doctors to handle diabetes complex treatments, increase specialists and healthcare teams reach and productivity, and provide better data to health programs and policies.
Our app automates diet and insulin doses calculations, alerts for medications and fixed dose insulin as prescribed, and registers all treatment data in a cloud based EMR. GlicOnline helps those patients who lack the discipline or educational level to understand and follow treatment correctly.
Multi professional teams are supported, and patients´ follow-up data is presented in graphs and tables specially designed to facilitate medical analysis. Specialists can intervene online, increasing their reach and productivity. Alarms on adherence and treatment events improve health teams efficiency. Quality data and reports improve manageability and enable pay for performance, reimbursement and optimized supply distribution programs.
2 - Knowledge
Dr Karla Melo, PhD - diabetes researcher and physician, who has diabetes herself - is one of the most respected specialists in Diabetes in Brazil. GlicOnline founder, Karla personal experience as patient, physician, educator and researcher shaped GlicOnline design, clinical trials and medical research.
An experienced diabetes educator, Karla is also responsible for GlicOnline education and training.
3 - Accreditation and support
GlicOnline is supported and endorsed by Brazil´s most prestigious professional and patients associations, including Brazilian Diabetes Society (SBD) and Diabetes Brazil Association (ADJ) .
Our clinical trials and research were in partnerships with USP (University of São Paulo), UNICAMP (University of Campinas) and FAMEMA (Marilia Medical School), and FAPESP.
As a social business, we are also an Endeavor company